CD28 and hepatocellular carcinoma: On the Treg panel, odds ratio (OR) of CD28- CD8br %CD8br on HCC risk was estimated to be 0.663 (95% CI 0.496–0.886, P = 5.434 × 10–3) by using IVW approach.